A new classifier-based strategy for in-silico ion-channel cardiac drug safety assessment
There is currently a strong interest in using high-throughput in-vitro ion-channel screening data to make predictions regarding the cardiac toxicity potential of a new compound in both animal and human studies. A recent FDA think tank encourages the use of biophysical mathematical models of cardiac...
| Autores principales: | , , |
|---|---|
| Formato: | Artículo |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2015-03-01
|
| Colección: | Frontiers in Pharmacology |
| Materias: | |
| Acceso en línea: | http://journal.frontiersin.org/Journal/10.3389/fphar.2015.00059/full |